Dr. Robert H. Goo, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Years since graduation
- 46
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 281
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
MI license 4301046558
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Beaumont Hospital Royal Oak Royal Oak, MI
- Beaumont Hospital - Farmington Hills Farmington Hills, MI
- Trinity Health Oakland Hospital Pontiac, MI
- Huron Valley-Sinai Hospital Commerce Township, MI
Medical groups
- Oakland Gastroenterology Associates, P.c. (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 281
- Services billed
- 577
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 217 | 164 |
| Established patient office or other outpatient visit, 30-39 minutes | 131 | 99 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 57 | 56 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 52 | 50 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 42 | 17 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 36 | 36 |
| New patient office or other outpatient visit, 45-59 minutes | 22 | 22 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 17 | 14 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | 17 |
| Biopsy of large bowel using a flexible endoscope | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in W Bloomfield, MI | 396 |
| Omeprazole Other prescribers in W Bloomfield, MI | 290 |
| Famotidine Other prescribers in W Bloomfield, MI | 109 |
| Creon (lipase/protease/amylase) Other prescribers in W Bloomfield, MI | 37 |
| Budesonide Ec (budesonide) Other prescribers in W Bloomfield, MI | 36 |
| Budesonide Dr (budesonide) Other prescribers in W Bloomfield, MI | 31 |
| Sucralfate Other prescribers in W Bloomfield, MI | 28 |
| Mesalamine Other prescribers in W Bloomfield, MI | 28 |
| Glycopyrrolate Other prescribers in W Bloomfield, MI | 26 |
| Esomeprazole Magnesium Other prescribers in W Bloomfield, MI | 21 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 100 payments worth $1,902 in total to this clinician.
| Janssen Biotech, Inc. | $435 |
|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $325 |
| AbbVie Inc. | $303 |
| Pfizer Inc. | $133 |
| Phathom Pharmaceuticals, Inc. | $115 |
| Genzyme Corporation | $91.30 |
| Aimmune Therapeutics, Inc. | $88.46 |
| Lilly USA, LLC | $83.55 |
| Food and Beverage | $1,817 |
|---|---|
| Education | $84.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Jun 11, 2025 | Education TREMFYA · Immunology · in-kind | $84.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.